Literature DB >> 22788262

Valuation of the Child Health Utility 9D Index.

Katherine Stevens1.   

Abstract

BACKGROUND AND OBJECTIVES: The aim of this study was to test the feasibility of estimating preference weights for all health states defined by the Child Health Utility 9D (CHU9D), a new generic measure of health-related quality of life for children aged 7-11 years. The estimation of preference weights will allow the calculation of QALYs for use in paediatric economic evaluation.
METHODS: Valuation interviews were undertaken with 300 members of the UK adult general population to obtain preference weights for a sample of the health states in the CHU9D descriptive system. Both standard gamble and ranking valuation methods were used. Regression modelling was undertaken to estimate models that could predict a value for every health state defined by the system. A range of models were tested and were evaluated based on their predictive performance.
RESULTS: Models estimated on the standard gamble data performed better than the rank model. All models had a few inconsistencies or insignificant levels and so further modelling was done to estimate a parsimonious consistent regression model using the general-to-specific approach, by combining inconsistent levels and removing non-significant levels. The final preferred model was an ordinary least squares (OLS) model. All the coefficients in this model were significant, there were no inconsistencies and the model had the best predictive performance and a low mean absolute error.
CONCLUSION: This research has demonstrated it is feasible to value the CHU9D descriptive system, and preference weights for each health state can be generated to allow the calculation of QALYs. The CHU9D can now be used in the economic evaluation of paediatric healthcare interventions. Further research is needed to investigate the impact of children's preferences for the health states and what methods could be used to obtain these preferences.

Entities:  

Mesh:

Year:  2012        PMID: 22788262     DOI: 10.2165/11599120-000000000-00000

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  23 in total

1.  The estimation of a preference-based measure of health from the SF-36.

Authors:  John Brazier; Jennifer Roberts; Mark Deverill
Journal:  J Health Econ       Date:  2002-03       Impact factor: 3.883

2.  Comparison of health state utility values derived using time trade-off, rank and discrete choice data anchored on the full health-dead scale.

Authors:  John Brazier; Donna Rowen; Yaling Yang; Aki Tsuchiya
Journal:  Eur J Health Econ       Date:  2011-09-30

Review 3.  Statistical versus quantitative significance in the socioeconomic evaluation of medicines.

Authors:  B J O'Brien; M F Drummond
Journal:  Pharmacoeconomics       Date:  1994-05       Impact factor: 4.981

4.  Valuing Child Health Utility 9D health states with a young adolescent sample: a feasibility study to compare best-worst scaling discrete-choice experiment, standard gamble and time trade-off methods.

Authors:  Julie Ratcliffe; Leah Couzner; Terry Flynn; Michael Sawyer; Katherine Stevens; John Brazier; Leonie Burgess
Journal:  Appl Health Econ Health Policy       Date:  2011       Impact factor: 2.561

5.  Using DCE and ranking data to estimate cardinal values for health states for deriving a preference-based single index from the sexual quality of life questionnaire.

Authors:  Julie Ratcliffe; John Brazier; Aki Tsuchiya; Tara Symonds; Martin Brown
Journal:  Health Econ       Date:  2009-11       Impact factor: 3.046

6.  Working with children to develop dimensions for a preference-based, generic, pediatric, health-related quality-of-life measure.

Authors:  Katherine J Stevens
Journal:  Qual Health Res       Date:  2010-01-06

7.  Multiattribute utility function for a comprehensive health status classification system. Health Utilities Index Mark 2.

Authors:  G W Torrance; D H Feeny; W J Furlong; R D Barr; Y Zhang; Q Wang
Journal:  Med Care       Date:  1996-07       Impact factor: 2.983

8.  Measuring preferences for health states worse than death.

Authors:  D L Patrick; H E Starks; K C Cain; R F Uhlmann; R A Pearlman
Journal:  Med Decis Making       Date:  1994 Jan-Mar       Impact factor: 2.583

9.  Health-related quality of life (HRQL) scores reported from parents and their children with chronic illness differed depending on utility elicitation method.

Authors:  L Sung; N L Young; M L Greenberg; M McLimont; T Samanta; J Wong; J Rubenstein; S Ingber; J J Doyle; B M Feldman
Journal:  J Clin Epidemiol       Date:  2004-11       Impact factor: 6.437

10.  Feasibility, reliability, and validity of the EQ-5D-Y: results from a multinational study.

Authors:  Ulrike Ravens-Sieberer; Nora Wille; Xavier Badia; Gouke Bonsel; Kristina Burström; Gulia Cavrini; Nancy Devlin; Ann-Charlotte Egmar; Narcis Gusi; Michael Herdman; Jennifer Jelsma; Paul Kind; Pedro R Olivares; Luciana Scalone; Wolfgang Greiner
Journal:  Qual Life Res       Date:  2010-04-17       Impact factor: 4.147

View more
  126 in total

1.  Valuing children's health: whose quality of life matters?

Authors:  Eve Wittenberg
Journal:  Pharmacoeconomics       Date:  2012-08-01       Impact factor: 4.981

Review 2.  How Well Do the Generic Multi-attribute Utility Instruments Incorporate Patient and Public Views Into Their Descriptive Systems?

Authors:  Katherine J Stevens
Journal:  Patient       Date:  2016-02       Impact factor: 3.883

Review 3.  An educational review of the statistical issues in analysing utility data for cost-utility analysis.

Authors:  Rachael Maree Hunter; Gianluca Baio; Thomas Butt; Stephen Morris; Jeff Round; Nick Freemantle
Journal:  Pharmacoeconomics       Date:  2015-04       Impact factor: 4.981

4.  Measuring Health-Related Quality of Life in Adolescent Populations: An Empirical Comparison of the CHU9D and the PedsQLTM 4.0 Short Form 15.

Authors:  Karin Dam Petersen; Gang Chen; Christine Mpundu-Kaambwa; Katherine Stevens; John Brazier; Julie Ratcliffe
Journal:  Patient       Date:  2018-02       Impact factor: 3.883

5.  Mapping CHU9D Utility Scores from the PedsQLTM 4.0 SF-15.

Authors:  Christine Mpundu-Kaambwa; Gang Chen; Remo Russo; Katherine Stevens; Karin Dam Petersen; Julie Ratcliffe
Journal:  Pharmacoeconomics       Date:  2017-04       Impact factor: 4.981

6.  Estimating Age- and Sex-Specific Utility Values from the CHU9D Associated with Child and Adolescent BMI z-Score.

Authors:  Anagha Killedar; Thomas Lung; Stavros Petrou; Armando Teixeira-Pinto; Alison Hayes
Journal:  Pharmacoeconomics       Date:  2020-04       Impact factor: 4.981

7.  A comparison of EQ-5D-3L population norms in Queensland, Australia, estimated using utility value sets from Australia, the UK and USA.

Authors:  Susan Clemens; Nelufa Begum; Catherine Harper; Jennifer A Whitty; Paul A Scuffham
Journal:  Qual Life Res       Date:  2014-03-28       Impact factor: 4.147

8.  The Child & Youth CompreHensIve Longitudinal Database for Deep Brain Stimulation (CHILD-DBS).

Authors:  Han Yan; Lauren Siegel; Sara Breitbart; Carolina Gorodetsky; Hernan D Gonorazky; Ivanna Yau; Cristina Go; Elizabeth Donner; Suneil K Kalia; Alfonso Fasano; Alexander G Weil; Aria Fallah; George M Ibrahim
Journal:  Childs Nerv Syst       Date:  2020-09-15       Impact factor: 1.475

9.  An intervention to improve the quality of life in children of parents with serious mental illness: the Young SMILES feasibility RCT.

Authors:  Kathryn M Abel; Penny Bee; Lina Gega; Judith Gellatly; Adekeye Kolade; Diane Hunter; Craig Callender; Lesley-Anne Carter; Rachel Meacock; Peter Bower; Nicky Stanley; Rachel Calam; Miranda Wolpert; Paul Stewart; Richard Emsley; Kim Holt; Holly Linklater; Simon Douglas; Bryony Stokes-Crossley; Jonathan Green
Journal:  Health Technol Assess       Date:  2020-11       Impact factor: 4.014

10.  Mapping PedsQLTM scores onto CHU9D utility scores: estimation, validation and a comparison of alternative instrument versions.

Authors:  Rohan Sweeney; Gang Chen; Lisa Gold; Fiona Mensah; Melissa Wake
Journal:  Qual Life Res       Date:  2019-11-19       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.